Archer Aviation: Why the “Smart Money” is Finally Placing Their Bets
The Wild West phase of flying cars is over. Here’s why ACHR is leading the pack in 2026.
Let’s be real—for a while there, investing in flying cars (eVTOLs) felt a bit like playing the lottery. You threw some cash at a cool-looking prototype and prayed they didn’t run out of money before the thing actually cleared takeoff.
But as we kick off 2026, that speculative fog is lifting. We’re entering the “Flight to Quality” era, and Archer Aviation (ACHR) just got a massive seal of approval from the biggest shark in the tank: BlackRock.
1. BlackRock Just Entered the Chat
When the world’s largest asset manager buys in, people notice. BlackRock recently bumped its stake in Archer to 8.1%, holding about 53 million shares. This isn’t an “activist” move where they try to fire the CEO; it’s a passive stake, which is basically financial shorthand for: “We like what you’re doing, keep it up.”
2. They Are Sitting on a Mountain of Cash
The biggest fear in aerospace is the “Valley of Death”—that awkward phase where you’re spending billions on testing but making zero dollars in revenue. Archer is currently laughing in the face of that valley. With a current ratio of 18.19, they have over $18 in liquid assets for every $1 they owe.
3. The Archer vs. Joby Plot Twist
For years, Archer and Joby Aviation were the “Pepsi and Coke” of the industry. But 2026 is seeing a breakup. While analysts have been cooling on Joby due to high valuation, Archer is increasingly seen as the value play. We’re seeing a “rotation”—investors are taking their wins from Joby and sliding them over to Archer.
4. The “Coiled Spring” (A.K.A. The Short Squeeze)
Here’s where it gets spicy for the traders. About 15% of Archer’s available shares are currently shorted. When big institutions like BlackRock “lock up” shares long-term, the supply disappears. If Archer drops some good news, those short sellers will have to scramble to buy back shares that aren’t there—potentially sending the price vertical.
The Bottom Line
With a Green Zone health rating and a price target sitting significantly higher than its current $8 mark, Archer is making a loud case for itself. They’ve got the tech, the manufacturing muscle, and now, the institutional street cred.